Traders Purchase High Volume of Put Options on Maravai LifeSciences
MRVI Stock | USD 4.77 0.20 4.38% |
Under 55% of Maravai Lifesciences' traders are presently thinking to get in. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that some investors are interested at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
Maravai |
Maravai LifeSciences Holdings, Inc. was the target of some unusual options trading activity on Wednesday. Traders acquired 1,002 put options on the stock. This represents an increase of approximately 1,791 percent compared to the average volume of 53 put options. Maravai LifeSciences Trading Down 2.7 percent Shares of NASDAQ MRVI opened
Read at thelincolnianonline.com
Maravai Lifesciences Fundamental Analysis
We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Maravai Lifesciences is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Maravai Lifesciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.
Peers
Maravai Lifesciences Related Equities
LEGN | Legend Biotech | 6.15 | ||||
INSM | Insmed | 5.85 | ||||
AKRO | Akero Therapeutics | 4.71 | ||||
HRMY | Harmony Biosciences | 3.61 | ||||
RARE | Ultragenyx | 3.20 | ||||
AGIO | Agios Pharm | 2.50 | ||||
ASND | Ascendis Pharma | 2.29 | ||||
INCY | Incyte | 2.14 | ||||
KRYS | Krystal Biotech | 2.13 | ||||
HALO | Halozyme Therapeutics | 2.08 | ||||
DNLI | Denali Therapeutics | 1.20 | ||||
ALEC | Alector | 1.17 | ||||
ROIV | Roivant Sciences | 1.08 | ||||
ARGX | Argenx NV | 1.07 | ||||
PTGX | Protagonist Therapeutics | 0.77 | ||||
APLS | Apellis Pharmaceuticals | 0.63 | ||||
FOLD | Amicus Therapeutics | 0.53 | ||||
ABUS | Arbutus Biopharma | 0.31 | ||||
CYTK | Cytokinetics | 0.17 | ||||
IMVT | Immunovant | 1.13 | ||||
EWTX | Edgewise Therapeutics | 1.72 | ||||
ARQT | Arcutis Biotherapeutics | 7.78 |
Complementary Tools for Maravai Stock analysis
When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |